Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Status Still investigational Retatrutide has Phase 3 data but no FDA-approved prescribing label yet
Many people who are interested in tirzepatide also have high blood pressure, insulin resistance, elevated cholesterol, prediabetes, type 2 diabetes, or other metabolic health concerns
You do not need to struggle anymore
Despite concerns about excessive weight loss, retatrutide will be an important addition for obesity patients when it's approved
Extended dose intervals Some providers experiment with extending the injection interval from weekly to every 10 days or even every 2 weeks
When taken through injections, Semaglutide/GLP-1 may impact the effectiveness of oral medications, including aspirin and other over-the-counter medications
US$ 20.95
US$ 21.25
US$ 24.94
US$ 24.94
US$ 25.35
US$ 27.62
US$ 22.74
US$ 20.44
